Country: United States
Hologic: Driving Innovation in Diagnostics and Women’s Health

Hologic is a leading American medical technology company known for its advanced diagnostic systems, breast health solutions, and minimally invasive medical technologies. The company has built a strong reputation for delivering innovative healthcare solutions designed to address some of the most complex medical challenges.

A major turning point came in 2007 with Hologic’s acquisition of Cytyc Corporation for $6.2 billion, significantly expanding its expertise in cervical cancer screening and women’s health. In 2012, the company further strengthened its capabilities in molecular diagnostics and infectious disease testing through the acquisition of Gen-Probe for $3.75 billion.

Hologic continued its expansion in 2017 by acquiring Cynosure for $1.65 billion, allowing the company to enter the field of non-surgical aesthetic treatments and energy-based medical solutions.

Backed by a history of strategic growth and innovation, Hologic remains committed to improving healthcare through cutting-edge technologies, accurate diagnostics, and patient-focused medical solutions.